Assyro AI

Orange Book product · Brand (NDA)

CYSVIEW KIT

HEXAMINOLEVULINATE HYDROCHLORIDE

Brand (NDA)NDA 022555RX PHOTOCURE ASA

At a glance

May 28, 2010

Approved

Brand (NDA)

Application

Not listed

TE code

3

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    May 28, 2010

    16 yr 4 mo ago

  2. Today

  3. Patent 10556010 expires

    Listed method-of-use patent (U-2250) expiration.

    Dec 19, 2036

    in 10 yr 8 mo

  4. Patent 11311620 expires

    Listed method-of-use patent (U-2250) expiration.

    Dec 19, 2036

    in 10 yr 8 mo

  5. Patent 11235168 expires

    Listed method-of-use patent (U-2250) expiration.

    Jan 04, 2038

    in 11 yr 9 mo

Pharmaceutical detail

Active ingredient

HEXAMINOLEVULINATE HYDROCHLORIDE

Strength

100MG/VIAL

Dosage form

FOR SOLUTION

Route

INTRAVESICAL

TE code

Not listed

Application

NDA 022555

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (3)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
10556010Dec 19, 2036in 10 yr 8 mo
U-2250
11311620Dec 19, 2036in 10 yr 8 mo
U-2250
11235168Jan 04, 2038in 11 yr 9 mo
U-2250
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.